Freenome
Freenome is a San Francisco-based company which uses genetic analysis for early cancer detection and risk assessment.
8
Funding Rounds
$967.6m
Money raised
Overview
Freenome is a San Francisco-based company which uses genetic analysis for early cancer detection and risk assessment.
-
Website:
- Business model: B2B
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company Freenome has raised a total of $460m in funding over 8 rounds.
Key Insights:
- Freenome Series D round, December 7, 2021: $300m
- Freenome Series B round, July 2019: $160m
- Freenome Seed round, June 2016: $5.6m
- Freenome funding round, March 2017: $65m
- Freenome Series A extension round, August 2017: $7m
- Freenome funding round, July 2019: $160m
- Freenome Series C round, August 2020: $270m
Freenome Series D round, December 7, 2021
$300m
Freenome Series B round, July 2019
$160m
Freenome Seed round, June 2016
$5.6m
Freenome funding round, March 2017
$65m
Freenome Series A extension round, August 2017
$7m
Freenome funding round, July 2019
$160m
Freenome Series C round, August 2020
$270m
Industries
Freenome is active in the following industries: